Skip to content
Screener

Axogen AXGN Price / sales

Price / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.8×-0.9×
Stryker logo
StrykerSYK
4.7×-1.5×
IAR
Integra LifeSciencesIART
0.8×+0.3×
LeMaitre Vascular logo
LeMaitre VascularLMAT
8.4×+0.2×
Artivion logo
ArtivionAORT
2.3×-1.3×
Bioventus logo
BioventusBVS
1.1×+0.3×

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.38B+277%
Enterprise value$2.31B+242%

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Calculated from Axogen’s reported figures.

Based on the most recent quarter.

The source filing: Axogen’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094

FAQ

What is Axogen's price / sales?
Axogen (AXGN) reported price / sales of 9.8× in Q2 2026.
How has Axogen's price / sales changed year-over-year?
Axogen's price / sales increased by 330.0% year-over-year, from 2.3× to 9.8×.
What is the long-term trend for Axogen's price / sales?
Over 5 years (2020 to 2025), Axogen's price / sales has grown at a 0.7% compound annual growth rate (CAGR), from 6.5× to 6.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Axogen's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude